SCHEMBL19366334

SCHEMBL19366334

CSc1ncc(C(O)c2c[nH]c3ncc(Cl)cc23)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.39
BRD4 O60885 1/20 0.38
CYP2C19 P33261 3/20 0.33
CYP3A4 P08684 3/20 0.33
BRAF P15056 3/20 0.32
CYP2D6 P10635 1/20 0.32
PKM P14618 1/20 0.32
CYP2C9 P11712 2/20 0.31
PDE10A Q9Y233 1/20 0.31
LCK P06239 2/20 0.31
CSF1R P07333 2/20 0.31
PDGFRB P09619 2/20 0.31
KIT P10721 2/20 0.31
PDGFRA P16234 2/20 0.31
FLT1 P17948 2/20 0.31
KDR P35968 2/20 0.31
FLT3 P36888 2/20 0.31
AURKB Q96GD4 2/20 0.31
BMPR1B O00238 1/20 0.31
PLK4 O00444 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26876461 0.78 JAK2 (0.45) JAK2BRD4CYP2C19CYP3A4CLK1
SCHEMBL14194694 0.78 BRD4 (0.45) JAK2BRD4CYP2C19CYP3A4CYP2D6
SCHEMBL18211756 0.77 MAP3K11 (0.47) JAK2BRD4CYP2C19CYP3A4BRAF
SCHEMBL26696343 0.77 JAK2 (0.44) JAK2BRD4CYP2C19CYP3A4BRAF
SCHEMBL19287905 0.75 BRD4 (0.43) JAK2BRD4CYP2C19CYP3A4BRAF
SCHEMBL21738169 0.73 JAK2 (0.50) JAK2CYP2C19CYP3A4BRAFCYP2D6
SCHEMBL26696371 0.72 DYRK1A (0.45) JAK2BRD4CYP3A4
SCHEMBL21872980 0.72 JAK2 (0.41) JAK2BRD4CYP2C19CYP3A4BRAF
SCHEMBL19829825 0.70 BRD4 (0.40) JAK2BRD4CYP2C19CYP3A4CYP2D6
Methylene Chloride SCHEMBL27892257 0.70 CYP2C9 (0.54) JAK2CYP2C19CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560972-B1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC (US) 2017-09-20 EP disclosed